申请人:PFIZER LTD
公开号:WO2011154871A1
公开(公告)日:2011-12-15
The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts thereof; to compositions containing such compounds; and to the of such compounds as inhibitors of HCV replication.
本发明涉及公式(I)的化合物及其药用盐;含有这种化合物的组合物;以及将这种化合物作为HCV复制抑制剂的方法。